NeoStem Announces Las Vegas Facility to Expand Nationwide Network of Cutting-Edge Adult Stem Cell Collection Centers
NeoStem, Inc. (OTCBB:
NEOI -
News), the first company to specialize in the collection, processing and storage of adult stem cells for personal use in times of critical medical need, has announced that the Company has entered into an agreement to open an Adult Stem Cell Collection Center in Las Vegas, Nevada.
The new center will serve clients interested in having their stem cells banked, as well as health professionals working in multibillion-dollar medical industries, including cancer, diabetes, multiple sclerosis, lymphoma and heart disease. Prospective clients for the new Las Vegas facility will include anyone concerned with their long-term health, well-being or risk of radiation exposure.
"Las Vegas provides an ideal destination for international travelers looking for an opportunity to enhance their own bio-insurance while vacationing in the United States," said Mark Weinreb, President of NeoStem.
The new center, which is scheduled to open this summer, will be among the world's first facilities to offer the collection, processing and long term banking of adult stem cells for an adult's own therapeutic use. NeoStem's proprietary processes allow patients to store their own stem cells for long periods of time to ensure immediate access in times of critical medical need. These cells are considered "autologous" as they are used by the donor exclusively for personal use to ensure biocompatibility.
"NeoStem is currently undergoing a very exciting phase of expansion as we continue to execute on our first-to-market, scaleable, business strategy," said Robin Smith, M.D., MBA, Chief Executive Officer of NeoStem. "This new facility exemplifies that growth, which we are hopeful will continue well into the future with a robust nationwide network."
"The promising use of adult stem cells to treat a widening range of diseases requires a high-quality, cost-effective infrastructure to make autologous stem cells available to patients," said Dr. Smith. "NeoStem is the first and still the only company providing this service to the medical community. We believe that the growing interest expressed by the healthcare community will quickly expand the number of our collection centers throughout the country."
With a collection center already open in California, NeoStem has begun processing and storing patients' stem cells, collected by trusted and experienced medical practitioners.
About NeoStem, Inc.
NeoStem offers pioneering services intended to capitalize on developing therapies in the thriving field of adult stem cell research. NeoStem offers its clients bio-insurance, including proprietary processes that provides health conscious individuals the opportunity to store their own (autologous) stem cells for long periods of time to ensure prompt access in times of critical medical need.
NeoStem's visionary senior management, its non-capital intensive business model and portfolio of first-to-market proprietary technology, will allow the Company to exploit a competitive advantage that leverages the burgeoning field of adult stem cell therapeutics, an anticipated multibillion dollar industry. Targeted markets for current adult stem cell treatments in development include autoimmune diseases, cancer, heart disease, diabetes, and many more.
NeoStem is committed to continue capitalizing on some of today's most promising therapeutics in development well into the 21st Century. For more information, please visit: www.neostem.com.
